Advertisement
Article| Volume 23, ISSUE 4, P326-334, February 15, 1988

Download started.

Ok

Increased level of salivary prostaglandins in patients with major depression

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      We quantified the amounts of salivary prostaglandin (PG) D2, PGE2, and PGF by radioimmunoassay in 32 patients with major depressive disorder, 16 patients with minor depressive disorder, 24 patients with neurotic disorders (panic, generalized anxiety, phobic, somatization, and obsessive compulsive), and 28 healthy controls. In the saliva of patients with major depressive disorder, the concentrations of immunoreactive PCs (PGD2, 385 ± 71 pg/ml; PGE2, 498 ± 105 pg/ml; PGF, 444 ± 100 pg/ml) were significantly higher than those of the healthy controls (PGD2, 129 ± 18 pg/ml; PGE2, 207 ± 25 pg/ml; PGF, 164 ± 17 pg/ml). On the other hand, the salivary concentrations of immunoreactive PCs from patients with minor depressive disorder or neurotic disorders were comparable to those of the controls. These results suggest that the level of salivary PCs may be an indicator of major depressive disorder.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abdel-Halim MS
        • Hamberg M
        • Sjöquist B
        • Anggård E
        Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain.
        Prostaglandins. 1977; 14: 633-643
        • Calabrese JR
        • Skwerer RG
        • Barna B
        • Dale Gulledge A
        • Valenzuela R
        • Butkus A
        • Subichin S
        • Krupp NE
        Depression, immunocompetence, and prostaglandins of the E series.
        Psychiatry Res. 1986; 17: 41-47
        • Coceani F
        Prostaglandins and the central nervous system.
        Arch Intern Med. 1974; 133: 119-129
        • Emilie D
        • Crevon MC
        • Galanaud P
        Prostaglandin E2 regulation of human specific B-cell response: Interaction with a monocyte product.
        Clin Immunol Immunopathol. 1983; 29: 415-423
        • Förstermann U
        • Heldt R
        • Knappen F
        • Hertting G
        Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain.
        Brain Res. 1982; 240: 303-310
        • Förstermann U
        • Heldt R
        • Hertting G
        Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandin E2 and F.
        Psychopharmacology. 1983; 80: 365-370
        • Goodwin JS
        • Webb DR
        Regulation of the immune response by prostaglandins.
        Clin Immunol Immunopathol. 1980; 15: 106-122
        • Gottlieb G
        • Paulson G
        Salivation in depressed patients.
        Arch Gen Psychiatry. 1961; 5: 468-471
        • Hedge GA
        • Hanson SD
        The effects of prostaglandins on ACTH secretion.
        Endocrinology. 1972; 91: 925-933
        • Horiguchi S
        • Ueno R
        • Hyodo M
        • Hayaishi O
        Alterations in nociception after intracisternal administration of prostaglandin D2, E2 or F to conscious mice.
        Eur J Pharmacol. 1986; 122: 173-179
        • Horning MG
        • Brown L
        • Nowlin J
        • Lertratanangkoon K
        • Kellaway P
        • Zion TE
        Use of saliva in therapeutic drug monitoring.
        Clin Chem. 1977; 23: 157-164
        • Inoué S
        • Honda K
        • Komoda Y
        • Uchizono K
        • Ueno R
        • Hayaishi O
        Differential sleeppromoting effects of five sleep substances nocturnally infused in unrestrained rats.
        in: Proc Natl Acad Sci USA. 81. 1984: 6240-6244
        • Jaffe BM
        • Behrman HR
        Prostaglandin E, A, and F.
        in: Jaffe BM Behrman HR Methods of Hormone Radioimmunoassay. Academic Press, Orlando, FL1974: 19-34
        • Kronfol Z
        • Silva J
        • Greden J
        • Dembinski S
        • Gardner R
        • Carroll B
        Impaired lymphocyte function in depressive illness.
        Life Sci. 1983; 33: 241-247
        • Kronfol Z
        • House JD
        • Silva J
        • Greden J
        • Carroll BJ
        Depression, urinary free cortisol excretion and lymphocyte function.
        Br J Psychiatry. 1986; 148: 70-73
        • Kuno S
        • Ueno R
        • Hayaishi O
        Prostaglandin E2 administered via anus causes immunosuppression in male but not female rats: A possible pathogenesis of acquired immune deficiency syndrome in homosexual males.
        in: Proc Natl Acad Sci USA. 83. 1986: 2682-2683
        • Lieb J
        • Karmali R
        • Horrobin D
        Elevated levels of prostaglandin E2 and thromboxane B2 in depression.
        Prostagland Leukotriens Med. 1983; 10: 361-367
        • Linnoila M
        • Whorton AR
        • Rubinow DR
        • Cowdry RW
        • Ninan PT
        • Waters RN
        CSF pros taglandin levels in depressed and schizophrenic patients.
        Arch Gen Psychiatry. 1983; 40: 405-406
        • Lipák J
        • Mözsik GY
        • Váczi B
        Parotid responses to indirect stimulation in patients with depressive illness.
        Acta Med Acad Sci Hung. 1971; 28: 159-171
        • Mathé AA
        False normal Dexamethasone Suppression Test and indomethacin.
        Lancet. 1982; ii: 714
        • Mathe AA
        • Eberhard G
        • Sääf J
        • Wetterberg L
        Plasma prostaglandin ez metabolite—measured as 11-deoxy-15-keto-13,14-dihydro-11β,16C-cyclo-PGE2—in twins with schizophrenic disorder.
        Biol Psychiatry. 1986; 21: 1024-1030
        • Narumiya S
        • Ogorochi T
        • Nakao K
        • Hayaishi O
        Prostaglandin D2 in rat brain, spinal cord and pituitary: Basal level and regional distribution.
        Life Sci. 1982; 31: 2093-2103
        • Ogorochi T
        • Narumiya S
        • Mizuno N
        • Yamashita K
        • Miyazaki H
        • Hayaishi O
        Regional distribution of prostaglandin D2, E2, and F and related enzymes in postmortem human brain.
        J Neurochem. 1984; 43: 71-82
        • Ohkubo T
        • Shibata M
        • Takahashi H
        • Inoki R
        Effect of prostaglandin D2 on pain and inflammation.
        Jpn J Pharmacol. 1983; 33: 264-266
        • Palmai G
        • Blackwell B
        The diurnal pattern of salivary flow in normal and depressed patients.
        Er J Psychiatry. 1965; 111: 334-338
        • Park SW
        • Ueno R
        • Hayaishi O
        Developmental changes in the activities of prostaglandin synthesizing enzymes in the digestive and immune systems of rat.
        Biochem Int. 1985; 10: 873-879
        • Peck RE
        The SHP test—An aid in the detection and measurement of depression.
        Arch Gen Psychiatry. 1959; 1: 35-40
        • Peng TC
        • Six KM
        • Munson PL
        Effects of prostaglandin e1 on the hypothalamo-hypophyseal-adrenocortical axis in rats.
        Endocrinology. 1970; 86: 202-206
        • Powell WS
        Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.
        Prostaglandins. 1980; 20: 947-957
        • Riad-Fahmy D
        • Read GF
        • Walker RF
        • Griffiths K
        Steroids in saliva for assessing endocrine function.
        Endocrinal Rev. 1982; 3: 367-395
        • Rigas B
        • Levine L
        Human salivary eicosanoids: Circadian variation.
        Biochem Biophys Res Commun. 1983; 115: 201-205
        • Roberts LJ
        • Sweetman BJ
        • Lewis RA
        • Austen KF
        • Gates JA
        Increased production of prostaglandin D2 in patients with systemic mastocytosis.
        N Engl J Med. 1980; 303: 1400-1404
        • Schleifer SJ
        • Keller SE
        • Meyerson AT
        • Raskin MJ
        • Davis KL
        • Stein M
        Lymphocyte function in major depressive disorder.
        Arch Gen Psychiatry. 1984; 41: 484-486
        • Schleifer SJ
        • Keller SE
        • Sins SG
        • Davis KL
        • Stein M
        Depression and immunity.
        Arch Gen Psychiatry. 1985; 42: 129-133
        • Schneyer LH
        • Schneyer CA
        Inorganic composition of saliva.
        in: Handbook of Physiology. vol 2. Waverlay Press, Baltimore1967: 497-530 (section 6)
        • Soter NA
        • Austen KF
        • Wasserman SI
        Oral disodium cromoglycate in the treatment of systemic mastocytosis.
        N Engl J Med. 1979; 301: 465-469
        • Spitzer RL
        • Endicott J
        • Robins E
        Research Diagnostic Criteria for a Selected Group of Functional Disorders.
        3rd ed. Biometrics Research Division, New York1978 (New York State Psychiatric Institute.)
        • Strongin EI
        • Hinsie LE
        Parotid gland secretions in manic-depressive patients.
        Am J Psychiatry. 1938; 94: 1459-1466
        • Toone BK
        • Lader MH
        Salivary secretion in the affective disorders and schizophrenia.
        Acta Psychiatr Scand. 1979; 59: 529-535
        • Ueno R
        • Ishikawa Y
        • Nakayama T
        • Hayaishi O
        Prostaglandin D2 induced sleep when microinjected into the preoptic area of conscious rats.
        Biochem Biophys Res Commun. 1982; 109: 576-582
        • Ueno R
        • Narumiya S
        • Ogorochi T
        • Nakayama T
        • Ishikawa Y
        • Hayaishi O
        Role of prostaglandin D2 in the hypothermia of rats caused by bacterial lipopolysaccharide.
        in: Proc Natl Acad Sci USA. 479. 1982: 6093-6097
        • Ueno R
        • Honda K
        • Inoué S
        • Hayaishi O
        Prostaglandin D2, a cerebral sleep-inducing substance in rats.
        in: Proc Natl Acad Sci USA. 80. 1983: 1735-1737
        • Ueno R
        • Osama H
        • Urade Y
        • Hayaishi O
        Changes of enzymes involved in prostaglandin metabolism and prostaglandin binding proteins in rat brain during development and aging.
        J Neurochem. 1985; 45: 483-489
        • Watanabe T
        • Narumiya S
        • Shimizu T
        • Hayaishi O
        Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma.
        J Biol Chem. 1982; 257: 14847-14853
        • Watanabe T
        • Shimizu T
        • Narumiya S
        • Hayaishi O
        NADP-linked 15-hydroxyprostaglandin dehydrogenase for prostaglandin D2 in human blood platelets.
        Arch Biochem Biophys. 1982; 216: 372-379
        • Yoshimura H
        • Inoue T
        • Imai Y
        Studies on mechanism of salivary secretion.
        Jpn J Physiol. 1962; 12: 476-483